Reports Monitor has recently published Global Personalized Medicines Market Research Report.
During last decade, pharmacogenomics has gained a huge attention in the treatment of the diseases such as cancer, diabetes, genetic diseases and others. Personalized medicines are manufactured according to the safety requirement of the patient or group of patients. The global personalized medicines market is majorly driven by increasing prevalence of cancer, and other chronic diseases, rapid development in the healthcare sector and increasing need for the better treatment options. Moreover, rising healthcare expenditure, and strong government support for research & development have fuelled the Personalized medicines market growth. However, long approval time, and high cost of manufacturing may slow the growth of the Personalized medicines market.
Get Access to Sample Pages @ https://goo.gl/w1As7U
The global personalized medicines market is expected to grow at a CAGR of 10.3% during the forecast period.
The global personalized medicines market is segmented on the basis of products, applications and end users.
On the basis of products, the market is segmented into personalized nutrition & wellness, personalized medical care, personalized diagnostic, personalized therapeutic. Personalized nutrition & wellness are further segmented into nutrition care, alternative medicines care, medical retail, and others. Personalized medical care is sub-segmented into telemedicine & remote patient monitoring, EMR, and other.
On the basis of application, the Personalized medicines market is segmented into disease treatment, biomarker identification, clinical research, and others. Disease treatment segment is further segmented into oncology, psychiatry, infectious diseases, cardiology, endocrinology, neurology, gastroenterology, rheumatology, and others.
On the basis of end users, the Personalized medicines market is segmented into hospitals & clinics, diagnostic laboratories and testing facilities, research laboratories & academic institutes, and others.
America commands the largest share in the Personalized medicines market owing to the huge patient population, and increasing demand for the better diagnostic and therapeutic treatments. Americas holds nearly half of the market share whereas the Middle East & Africa holds least. Asia Pacific region shows the fastest growth for the market owing to presence of huge opportunities for the market development and increasing healthcare expenditure.
The key players in the Personalized medicines market are: Siemens Healthcare GmbH (Germany), Quest Diagnostics (U.S.), Sanofi (France), Pfizer Inc. (U.S.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN (Germany), CELERA (U.S.), Amgen (U.S.), and 23andme (U.S.)
Segmentation Covered
By Products - Personalized Nutrition & Wellness, Nutrition Care, Alternative medicines care, Medical Retail, Others, Personalized Medical Care, Telemedicine & Remote Patient Monitoring, EMR, Other, Personalized Diagnostic, Personalized Therapeutic
By Applications - Disease Treatment, Oncology, Lung Cancer, Breast Cancer, Prostate Cancer, Others, Psychiatry, Infectious Diseases, HIV, Hepatitis B, Others, Cardiology, Endocrinology, Neurology, Gastroentrology, Rheumatology, Others, Biomarker Identification, Clinical Research, Others
By End Users - Hospitals & clinics, Diagnostic laboratories and testing facilities, Research Laboratories & Academic institutes, Others
View Full Report @ https://goo.gl/wVVZrq
We periodically update our market research studies to ensure our clients get the most recent, relevant, and valuable information. Reports Monitor has a strong base of analysts and consultants from assorted areas of expertise. Our industry experience and ability to zero-in on the crux of any challenge gives you and your organization the ability to secure a competitive advantage.
No comments:
Post a Comment